Antidepressants induce resilience and reverse susceptibility

February 2, 2017 by Elsevier, Elsevier

When they work, antidepressant medications may take weeks or months to alleviate symptoms of depression. Progress in developing new and more effective antidepressant treatments has been limited, though a new study published in Biological Psychiatry offers new insights into how antidepressants work.

Using a mouse model of depression, researchers found that a therapeutic response to antidepressant medication may stem from changes in gene expression that induce resilience and reverse vulnerability to exhibiting depression-like responses to stress. The study, led by Dr. Eric Nestler of the Icahn School of Medicine at Mount Sinai in New York, teases apart the mechanisms of two different antidepressant drugs- the conventional tricyclic antidepressant imipramine and fast-acting ketamine.

Depression-like symptoms were induced in mice using a chronic social defeat stress model, which causes physiological and behavioral changes that model depression in humans. Using genome-wide assays to study gene transcription in mice that either succumbed to the stress paradigm or were unaffected, the researchers identified specific transcriptional changes associated with susceptibility or resilience. Then they treated the mice exhibiting depression-like symptoms with repeated imipramine or single-dose ketamine, and looked for those susceptible-specific or resilience-specific changes induced by the drugs. Importantly, each treatment reversed the depression-like symptoms of a roughly equivalent fraction of the mice.

Co-first authors Dr. Rosemary Bagot and Hannah Cates and colleagues examined four different emotion-related brain regions implicated in depression, and found that both imipramine and ketamine exerted strong effects in the prefrontal cortex. As a result, this region could be a common and potentially essential target for antidepressant action. The different brain regions also displayed changes in gene expression unique to each of the drugs, which may be the source of drug-specific effects.

"Antidepressant effects on resilience are an important new area of study. This study suggests that both traditional and rapid-acting antidepressant medications induce a biochemical fingerprint of resilience in brain regions associated with the regulation of emotion," said Dr. John Krystal, Editor of Biological Psychiatry. Both drugs also induced patterns of gene expression that strongly opposed susceptible-specific gene expression, suggesting a reversal of susceptibility.

Not all mice showed improvement of their symptoms with antidepressant treatment. Those that lacked a response to treatment failed to show changes that were observed in treatment-responders. Unique changes in the non-responders also suggest that rather than just failing to respond, alterations in the brain may actually oppose the effects of medication.

"The work provides uniquely broad and novel insight into the mechanism of action of two across several , including why certain individuals respond behaviorally to the treatments while others do not," said Dr. Nestler. "The findings offer a template for future drug discovery efforts aimed at validating novel targets for antidepressant therapeutics."

Explore further: Antidepressant effects of ketamine

More information: Rosemary C. Bagot et al. Ketamine and Imipramine Reverse Transcriptional Signatures of Susceptibility and Induce Resilience-Specific Gene Expression Profiles, Biological Psychiatry (2017). DOI: 10.1016/j.biopsych.2016.06.012

Related Stories

Antidepressant effects of ketamine

December 8, 2016
New preclinical evidence was put forward by investigators in a series of presentations at the recent meeting of the American College of Neuropsychopharmacology suggest that the a metabolite of ketamine can produce antidepressant-like ...

How depression and antidepressant drugs work

May 18, 2016
New research demonstrates the effectiveness of ketamine to treat depression in a mouse model of the disease and brings together two hypotheses for the cause of depression. The research, led by Bernhard Lüscher, professor ...

mTOR: A key brain signaling mechanism for rapidly acting antidepressants

November 19, 2013
Two years ago, mammalian target of rapamycin or mTOR, a signaling protein, was identified as a key mediator of the antidepressant effects of ketamine, the first rapidly acting antidepressant medication to be identified.

Research shows why ketamine is an effective antidepressant but memantine is not

May 27, 2014
(Medical Xpress)—Ketamine is a fast-acting antidepressant. However, it can create symptoms that mimic psychosis. Therefore, doctors don't give it to depressed patients. Memantine, a similar drug, does not have psychotomimetic ...

Scientists find new path in brain to ease depression

October 5, 2016
Northwestern Medicine scientists have discovered a new pathway in the brain that can be manipulated to alleviate depression. The pathway offers a promising new target for developing a drug that could be effective in individuals ...

A potential new class of fast-acting antidepressant

October 29, 2013
More than 1 in 10 Americans take antidepressants, but these medications can take weeks—and for some patients, months—before they begin to alleviate symptoms. Now, scientists from the University of Chicago have discovered ...

Recommended for you

Neuroimaging study reveals 'hot spot' for cue-reactivity in substance-dependent population

November 20, 2018
When patients with dependence on alcohol, cocaine or nicotine are shown drug cues, or images related to the substance, an area of their brain known as the medial prefrontal cortex (mPFC) shows increased activity, report investigators ...

Being fair: The benefits of early child education

November 20, 2018
Children from low-income families who got intensive education early in life treat others with high levels of fairness in midlife, more than 40 years later, even when being fair comes at a high personal cost, according to ...

Does Netflix's '13 Reasons Why' influence teen suicide? Survey asks at-risk youths

November 20, 2018
A significant proportion of suicidal teens treated in a psychiatric emergency department said that watching the Netflix series "13 Reasons Why" had increased their suicide risk, a University of Michigan study finds.

MDMA makes people cooperative, but not gullible

November 19, 2018
New research from King's College London has found that MDMA, the main ingredient in ecstasy, causes people to cooperate better—but only with trustworthy people. In the first study to look in detail at how MDMA impacts cooperative ...

Exploring the genetic contribution to suicide risk

November 19, 2018
Researchers at University of Utah Health identified four gene changes that occur more frequently in people who died by suicide that may point to increased risk in vulnerable individuals.

Response to daily stressors could affect brain health in older adults

November 19, 2018
Taking typical daily annoyances such as a long wait at the doctor's office or a traffic jam on the freeway in stride may help preserve brain health in older adults, while emotional reactions could contribute to declines in ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.